Fecal Transplant Overcomes Nivolumab Resistance in Melanoma

Fecal Transplant Overcomes Nivolumab Resistance in Melanoma

In a miniature scientific trial, fecal transplants restored the response to immunotherapy in 3 of 10 patients with refractory metastatic melanoma whose prerequisites had stopped responding to therapy with anti–programmed cell death–ligand-1 (anti-PD-LI) treatment. One in all these patients had…

AHA 2020 Highlights: Skill Bellow Changers

AHA 2020 Highlights: Skill Bellow Changers

discontinuance Please verify that you just may are attempting to log off of Medscape. While you log off, you may maybe maybe be required to enter your username and password the subsequent time you talk to. Log off Break Steve…